Investigation of cytokines and herpes simplex virus in recurrent abortion in pregnant women
  • Article Type: Research Article
  • Eurasian Journal of Biosciences, 2020 - Volume 14 Issue 2, pp. 2613-2624
  • Published Online: 28 Aug 2020
  • Open Access Full Text (PDF)

Abstract

This study aimed to investigate the existence of Herpes simplex virus (HSV) type1 and type 2 in abortion women as well as to detect the role of cytokines in the induction of abortion. Over the period from November (2019) to February (2020), a total of 68 cases of abortion women Collected from Al-Zahraa Teaching Hospital in AL-Najaf city, and the women’s generating of children teaching hospital Kerbala. Furthermore, the control group relied on 20 healthy pregnant women without any evidence of chronic inflammatory disease, two types of cases with ages ranging from 16-40 years. Blood samples were obtained from abortion women and healthy controls were tested for HSV-1 and HSV-2 tested first on Rapid ICT Kits. Of the 68 samples, 9(13%) were positive, and 59(87%) were negative in Rapid Immunochromatographic Test (ICT), While the results of pregnant women’s investigation showed Nil(0%) negative result for every 20 samples these findings were then verified by using Enzyme-Linked Immunosorbent Assay (ELISA) technique to investigate HSV type1 and type 2 where attained 38(56%) positive samples in the aborted women and 8(40%) positive samples in the pregnant women respectively. Collected samples from abortion women and control estimate immunological level (IL-2, IL-10 & TFN-α, C3) Used the ELISA and radial immunodiffusion method. The results revealed the sensitivity of rapid (ICT) compare to the ELISA technique was 11 %. This ratio indicates the true positive HSV infection and the specificity was 92% indicate to the true negative infection with HSV. And the positive cases of HSV-1and HSV-2 in aborted women were recorded 27(40%) at the first trimester. In another side, the other cases of abortion occurred in the second and third trimester were reached (16/68) and (1/68) respectively. The Cytokine tests. High significance (p<0.05) of IL-2 in aborted + HSV women (3.994±0.9354) and aborted -HSV women (4.655±1.423) compared to control pregnant women (2.903±0.7484) whereas there was a non-significant difference between aborted + HSV women and aborted -HSV women. The results of this study revealed a high level of IL-2 in the serum of aborted women as positive and negative for HSV compared with pregnant women. While the result of IL-10 level showed great significance (p<0.05) in aborted +HSV women(2.709 ± 0.3877),aborted -HSV women(2.905 ± 0.3368) compared with control (pregnant) women (2.267 ± 0.2332) But there is no -significant difference (p<0.05) among aborted +HSV women and aborted –HSV . On the other hand Results showed great significance (p<0.05) of TNF-α level in aborted +HSV women(4.859 ± 0.6083),aborted -HSV women(4.770 ± 0.4548) compared with control (pregnant) women (4.841 ± 0.4153) while there was non-significant difference (p<0.05) among aborted +HSV women and aborted –HSV women. In the present study, the results detected high significance (p<0.05) in the levels of C3 for aged group ≥ 42 (85.80±24.63 mg/dl)in comparison to the control(79.10 ±4.890 mg/dl).

References

  • A Naqid I, H Yousif S, R Hussein N (2020). Seroprevalence of Rubella and Herpes Simplex Virus in Women with Miscarriage and Stillbirth in Zakho City, Kurdistan Region, Iraq: A Cross-Sectional Study. Women’s Health Bulletin.7(1):8-12.
  • Abbas AH, AL-Warid HS, Salloom DF (2011). Evaluation of complements serum level (C3 and C4) in pregnant women with a history of toxoplasmosis. Journal of Biotechnology Research Center. 5(2):12-16Bilal M, Khan RA, Ahmed A, Afroz S (2011) Partial evaluation of technique used in cupping. Journal of Basic and Applied Science 7(1): 65-68.
  • Abu-Madi MA, Behnke JM, Dabritz HA (2010). Toxoplasma gondii seropositivity and co-infection with TORCH pathogens in high-risk patients from Qatar. The American Journal of Tropical Medicine and Hygiene.82(4):626-633.
  • AL-Fatlawi SN, Sultan BA. (2016). Assessment of C3 and C4 component of the complement system in aborted women infected with Toxoplasma gondii. Al-QadisiyahMedicalJournal.12(22):110-114.
  • Aljumaili ZKM, Alsamarai AM, Najem WS (2013). Seroprevalence of Herpes Simplex Virus Type 2 (HSV 2) in women with bad obstetric history. American Journal of Dermatology and Venereology.2(3):31-38.
  • Al-khayat ZA, Waheda NE, Shaker NF (2014). Complement C3 and C4 Levels in Recurrent Aborting Women with or without Antiphospholipid and Anticardiolipin Autoantibodies. Ibnosina Journal of Medicine and Biomedical Sciences. 6(5):213-218.
  • AL-Khilkhali HJ, Shubbar EE, Amjed MM, Mohsen NS, Abed Zaid ZY (2019). Using rapid and ELISA tests for detecting hepatitis C virus and human immunodeficiency virus among healthy and renal failure population. Journal of Global Pharma Technology.11 (02 suppl):48-55.
  • Al-Samarrae EAA (2010). Study the Relationship of Toxoplasma IgG Titer with Some Other immunoglobulin and Complement Components. Iraq Journal CommunityMedicine.23(2):127-129.
  • Al-Sheikh SK, Jasim AN, Ad’hiah AH (2007). Some immunologic evaluations of toxoplasmosis in Iraqi aborted females. Baghdad Science Journal. 4(3):444-451.
  • Alzamil HA, Parade J, Fortier MA, Bernal AL (2014). Expression of the prostaglandin F synthase AKR1B1 and the prostaglandin transporter SLCO2A1 in human fetal membranes about the spontaneous term and preterm labour. Frontiers in physiology.5, 272.
  • Arshad Z, Alturkistani A, Brindley D, Lam C, Foley K, Meinert E (2019). Tools for the diagnosis of herpes simplex virus 1/2: a systematic review of studies published between 2012 and 2018. JMIR public health and surveillance. 5(2),e14216.
  • Azizieh FY, Raghupathy RG (2015). Tumour necrosis factor-α and pregnancy complications: a prospective study. Medical Principles and Practice.24(2):165-170.
  • Cao Y, Zhang Z, Zheng Y, Yuan W, Wang J, Liang H, Shen Y (2014). The association of idiopathic recurrent early pregnancy loss with polymorphisms in folic acid metabolism-related genes. Genes and nutrition. 9(3), 402.
  • Cheng SB, Sharma S (2015). Interleukin‐10: a pleiotropic regulator in pregnancy. American Journal of Reproductive Immunology.73(6):487-500.
  • Conroy AL, McDonald CR, Silver KL, Liles WC, Kain KC (2011). Complement activation: a critical mediator of adverse fetal outcomes in placental malaria.Trends in parasitology.27(7).294-299.
  • Crimi S, Fiorillo L, Bianchi A, D’Amico C,Amoroso G, Gorassini F, Campagna P (2019). Herpes Virus, Oral Clinical Signs and QoL: Systematic Review of Recent Data. Viruses. 11(5), 463.
  • Dunkelberger JR, Song WC (2010). Complement and its role in innate and adaptive immune responses. Cell Research.20(1):34-50.
  • Elenkov IJ, Wilder RL, Bakalov VK,Link AA, Dimitrov MA, Fisher S, Chrousos GP (2001). IL-12, TNF-α, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. The Journal of Clinical Endocrinology and Metabolism.86(10): 4933-4938.
  • Ghaseminia, F., Daneshian, J., Soleimany, B., & Afghah, M. (2016). The Role of Stratigraphy in Growth Strata Studies: A Case Study from the Middle-Late Cretaceous Deposits in Persian Gulf, SW Iran. International Journal of Geography and Geology, 5(12), 249-258.
  • Girardi G, Bulla R, Salmon JE, Tedesco F (2006). The complement system in the pathophysiology of pregnancy. Molecular Immunology Journal Elsveir.43(2):48-77.
  • Grimes DA, Stuart G (2010). Abortion jabberwocky: The need for better terminology Contraception.81(2):93-96.
  • Habib MA (2009). IFN-γ versus IL-10 in situ expression in recurrent spontaneous abortion. Iraqi Journal of Medical Sciences, 7(1), 21-29.
  • Holers VM, Girardi G, Mo L, Guthridge JM, Molina H, Pierangeli SS, Salmon JE (2002). Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. The Journal of experimental medicine.195(2):211-220.
  • Homes VA, Wallace JM, Gilmore WS, Mcfaul P, Alander HD (2003). Plasma levels of the immunomodulatory cytokine interleukine -10 during normal human pregnancy: a longitudinal study. Cytokine. 21(6):265-269.
  • Hussan BM (2013). Study the prevalence of ACL, APL, CMV, HSV, Rubella, and Toxoplasma gondii in aborted women in Baghdad. Medical Journal of Babylon.10(2):455-464.
  • Iche KE (2014). Seroprevalence of herpes simplex virus infections among pregnant women attending antenatal clinic in Benin, Nigeria. International Journal Tropical Disease andHealth.4(1):70-81.
  • Kamali M, Hantoushzadeh S, Boma S, Neamatzadeh H, Mazaheri M, Noor Shadkam M (2018).Association between thrombophilic genes polymorphisms and recurrent pregnancy loss
  • Kapranos NC, Kotronias DC (2009). Detection of herpes simplex virus in first-trimester pregnancy losing molecular techniques. In vivo.23(5):839-842.
  • Karad D, Kharat A (2015). Seroprevalence of Torch Infections in Bad Obstetrics History in HIV and NonHIV Women in Solapur District of Maharashtra India. Journal Human Virol Retrovirol.2(7):1-7
  • Kaur A., and Kaur, A. (2011). Recurrent pregnancy loss: TNF-α and IL-10 polymorphisms. Journal of Human Reproductive Sciences.4(2):91-94.
  • Kolawole OM, Amuda OO, Nzurumike C, Suleiman MM, Ogah JI (2016). Seroprevalence and co-infection of the human immunodeficiency virus (HIV) and herpes simplex virus (HSV) among pregnant women in Lokoja, North-Central Nigeria. Iranian Red Crescent Medical Journal, 18(10):e25284.
  • Kolte AM, Olsen LR, Mikkelsen EM, Christiansen OB, Nielsen HS (2015). Depression and emotional stress are highly prevalent among women with recurrent pregnancy loss. Human reproduction.30(4): 777-782.
  • Kriebs JM (2008). Understanding herpes simplex virus: transmission, diagnosis, and considerations in pregnancy management. Journal of midwifery & women’s health.53(3): 202-208.
  • Liao W, Lin JX, Leonard WJ (2013). Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity.38(1):13-25.
  • Loeffelholz MJ (2002). Rapid diagnosis of viral infections. Laboratory Medicine.33(4):283-286.
  • Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Gottlieb SL, Newman, L. M (2015). Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PloS one.10(10):e140765.
  • Marchi S, Trombetta CM, Gasparini R, Temperton N, Montomoli E (2017). Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014. Journal of preventive medicine and hygiene. 58(1): 27-33.
  • Mawak JD, Dashe N, Atseye AB, Agabi YA, Zakeri H (2012). Seroprevalence and co-infection of herpes simplex virus type 2 and human immunodeficiency virus in Nigeria.‏ Shiraz E-Medical Journal.13(1):12-44.
  • Michimata T, Sakai M, Miyazaki S, Ogasawara MS, Suzumori K, Aoki K, Saito S (2003). Decrease of T‐helper 2 and T‐cytotoxic 2 cells at implantation sites occurs in unexplained recurrent spontaneous abortion with normal chromosomal content. Human Reproduction.18(7):1523-1528.
  • Miyazaki S, Tsuda H, Sakai M, Hori S, Sasaki Y, Futatani T, Saito S (2003). The predominance of Th2‐promoting dendritic cells in early human pregnancy decidua. Journal of leukocyte biology.74(4):514-522.
  • Mohaimen NA, Majid A (2011). Evaluation of IL-2, IL-8, IL-10 expression in trophoblastic tissue of women with spontaneous miscarriage infected by Toxoplasma gondii. Al-Anbar Medical Journal.9(1):50-58.
  • Mohammad EAK, Salman YJ (2014). Study of TORCH infections in women with Bad Obstetric History (BOH) in Kirkuk city. International Journal of Current Microbiology and Applied Sciences. 3(10):700-709
  • Money D, Steben M (2009). SOGC clinical practise guidelines: Guidelines for the management of herpes simplex virus in pregnancy. Number 208, June 2008. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.104(2):167-171.
  • Neamatzadeh H, Ramazani V, Kalantar SM, Ibrahimi M, Sheikhha MH (2016). Serum immune reactivity against β2-Glycoprotein 1 and anti-neutrophil cytoplasmic autoantibodies by ELI- P-Complex Screening Technology in recurrent miscarriage.Minerva Gynecol.68(3):243-249.
  • Obaid HM, Juma SA (2017). TORCH screening test in pregnant women of Kirkuk city. Al-Mustansiriyah Journal of Science.27(5):17-25.
  • Pandey MK, Rani R, Agrawal S (2005). An update in recurrent spontaneous abortion. Archives of gynaecology and obstetrics. 272(2):95-108.
  • Parameswaran N, Patial S (2010). Tumour necrosis factor-α signalling in macrophages. Critical Reviews™in Eukaryotic Gene Expression. 20(2):87-103.
  • Raghupathy R, Makhseed M, Azizieh F, Omu A, Gupta M, Farhat R (2000). Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Human reproduction.15(3):713-718.
  • Rasti S, Ghasemi FS, Abdoli A, Piroozmand A, Mousavi SGA, Fakhrie‐Kashan Z (2016). ToRCH “co‐infections” are associated with an increased risk of abortion in pregnant women. Congenital anomalies.56(2):73-78.
  • Rezaei A, Dabbagh A (2002). T-helper (1) cytokines increase during early pregnancy in women with a history of recurrent spontaneous abortion. Medical Science Monitor.8(8):607-610.
  • Sadik MS, Fatima H, Jamil K, Patil C (2012). Study of TORCH profile in patients with a bad obstetric history. Biology and Medicine, 4(2):95-101.
  • Saini V, Arora S, Yadav A, Bhattacharjee J (2011). Cytokines in recurrent pregnancy loss. Clinica Chimica Acta, 412(9-10), 702-708.
  • Saleh DS, Kharibet KE (2015). Detection of Cytomegalovirus, Rubella virus, and IL-2 Leve Sample of Recurrently Aborted Iraqi Women. Iraqi Journal of Science.56(3A):1890-1894.
  • Salman YJ (2007). Serological cross-reaction among causative agents of women abortions (toxoplasma, CMV, rubella, hepatitis B, and C. Tikrit Journal of Pharmaceutical Sciences. 3(20):102-111.
  • Silver RM, Branch DW, Goldenberg R, Iams JD, Klebanoff MA (2011). Nomenclature for pregnancy outcomes: time for a change. Obstetrics & Gynecology. 118(6): 1402-1408.
  • Song L, Shen L, Mandiwa C, Yang S, Liang Y, Yuan J, Wang Y (2017). Induced and spontaneous abortion and risk of uterine fibroids. Journal of Women’s Health. 26(1):76-82.
  • Sugiura-Ogasawara M, Nozawa K, Nakanishi T, Hattori Y, Ozaki Y (2006). Complement as a predictor of further miscarriage in couples with recurrent miscarriages. Human Reproduction. 21(10): 2711-2714.
  • susceptibility in the Iran population. A systematic review and meta-analysis Iranian Biomedical Journal.22(2):78-89.
  • Thellman NM, Triezenberg SJ (2017). Herpes Simplex Viru Establishment, Maintenance, and Reactivation: VitroModeling of Latency. Pathogens. 6(3), 28.
  • Wald A, Ashley-Morrow R (2002). Serological testing for herpes simplex virus (HSV) –1 and (HSV)-2 infection. Clinical infectious diseases.35(2):173-182.
  • Whitcomb BW, Schisterman EF, Klebanoff MA, Baumgarten M, Luo X, Chegini N (2008). Circulating levels of cytokines during pregnancy: thrombopoietin is elevated in miscarriage. Fertility and sterility. 89(6):1795-1802.
  • Wood S (2011). Answering questions about herpes in pregnancy. The Journal of perinatal education. 20(1):61-64.
  • World Health Organisation. (2012). Safe abortion: technical and policy guidance for health systems. 2nd Edition. Geneva.WHO.123.
  • Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H (2000). A critical role for murine complement regulator carries in fetomaternal tolerance. Science.287(5452):498-501.
  • Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, Markowitz LE (2006). Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. Journal of the American Medical Association. 296(8):964-973.
  • Yezlankyzy T, Niazbekov S (2015). Abortion Is the Same as a Murder of an Innocent Human Being. International Student’s Journal of Medicine.1(4):23-30.

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.